Teresa Leezer of RhinoCyte, Inc. joined us for World Orphan Drug Congress USA 2015 to present about ‘ Autologous Neural Stem Cell Therapies for Neurodegenerative Diseases’
Download the presentation here to understand more about:
- RhinoCyte key product attributes
- Investigational New Drug (IND) Submission in Spinal Cord Injury
- Phase I/II Multi-center Trial
- RhinoCyte Financial Status
- Value Proposition
…and much more!
Get your copy here!
To find out more about how RhinoCyte is working to commercialize autologous neural stem cell therapies for neurodengerative diseases , join us at World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.